Kengo Kusano

Apr 9, 2024 | uscjournal.com | Kengo Kusano |William F McIntyre |William Mcintyre

ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study. Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation.

Jun 1, 2023 | jacc.org | Nobuhiko Ueda |Takashi Noda |Kengo Kusano |Satoshi Yasuda

JACC Journals › JACC: Asia › Archives › Vol. 3 No. 3_Part_1 AbstractThe effectiveness of primary prevention implantable cardioverter-defibrillators (ICDs) is well established. However, there are several unsolved problems related to ICD use for primary prevention in Asia, including ICD underuse, population differences in underlying heart disease, and the rate of appropriate ICD therapy compared with Western countries.